Literature DB >> 7159876

Natural antibody to a human bladder carcinoma cell line.

H B Grossman.   

Abstract

Sera from 144 healthy blood donors were screened for the presence of antibody against the bladder carcinoma cell line RT4 by means of an immune adherence assay. Only one serum (9241) demonstrated high activity with a titer of 1/124. Qualitative and quantitative absorption analyses were carried out with a wide variety of cells to characterize the specificity of the reaction. Cells used for absorption were both cultured and non-cultured and normal and malignant. The reactivity was absorbed by the bladder cancer cell lines RT4 and 5637 and the lung cancer cell line SK-LC-LL. In addition, surgically obtained urothelium from a patient with transitional cell carcinoma abrogated reactivity. No other absorbing cells removed the reactivity of serum 9241 for RT4. The antigen defined by this serologic reaction is heat-stable and trypsin-resistant, as demonstrated by using heated or trypsinized RT4 cells for absorption. This study shows that naturally occurring antibody directed toward cell surface antigens of tumor cells is present in some normal individuals. This finding is important in the evaluation of a possible causal relationship between the presence of antibody specific for tumor cell antigens and the development of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159876     DOI: 10.1007/bf00205306

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  Serial multiple-site biopsies in patients with bladder cancer.

Authors:  M S Soloway; W Murphy; M K Rao; C Cox
Journal:  J Urol       Date:  1978-07       Impact factor: 7.450

2.  Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.

Authors:  H Shiku; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

3.  Serological analysis of cell surface antigens of malignant human brain tumors.

Authors:  M Pfreundschuh; H Shiku; T Takahashi; R Ueda; J Ransohoff; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.

Authors:  T E Carey; K O Lloyd; T Takahashi; L R Travassos; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Specific red cell adherence: immunologic evaluation of random mucosal biopsies in carcinoma of the bladder.

Authors:  B S Stein; J M Reyes; R O Petersen; D McNellis; A R Kendall
Journal:  J Urol       Date:  1981-07       Impact factor: 7.450

Review 6.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

Authors:  L J Old
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

7.  Detection of antibody to autologous human leukemia cells by immune adherence assays.

Authors:  T J Garrett; T Takahashi; B D Clarkson; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

8.  Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

Authors:  T E Carey; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Cell surface antigens of human renal cancer defined by autologous typing.

Authors:  R Ueda; H Shiku; M Pfreundschuh; T Takahashi; L T Li; W F Whitmore; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

10.  Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.

Authors:  A N Houghton; M C Taormina; H Ikeda; T Watanabe; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

View more
  1 in total

1.  Autologous antibodies to human bladder cancer.

Authors:  H B Grossman; G Wedemeyer; J Stein
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.